FIELD: medicine.
SUBSTANCE: invention relates to medicine, physiotherapy and can be used for the rehabilitation of patients after a new coronavirus infection (COVID-19) with a clinical variant of an acute respiratory viral infection - damage to the upper respiratory tract. Normoxic barotherapy is carried out at an excess pressure of 0.15-0.35 atm with an oxygen content of up to 30% and a flow rate of 5 l/min. The exposure time is 30 minutes, the course is 8-16 procedures. Normoxic barotherapy is combined with daily walks in the natural landscape of the forest park.
EFFECT: method enables stimulation of capillary blood flow and blood supply, activation of intracellular and intercellular processes.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMPREHENSIVE REHABILITATION OF PATIENTS AFTER NEW CORONAVIRUS INFECTION (COVID-19) | 2021 |
|
RU2748452C1 |
| METHOD FOR PERSONALIZED REHABILITATION OF PATIENTS WITH HASHIMOTO THYROIDITIS AFTER SUFFERING A NEW CORONAVIRUS INFECTION (COVID-19) | 2021 |
|
RU2750407C1 |
| METHOD FOR REHABILITATION OF PATIENTS SUFFERING BILATERAL PNEUMONIA ASSOCIATED WITH NOVEL CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2820281C1 |
| METHOD OF MEDICAL REHABILITATION OF PATIENTS AFTER PNEUMONIA ASSOCIATED WITH NEW CORONAVIRUS INFECTION (COVID-19) | 2022 |
|
RU2809654C1 |
| METHOD OF TREATMENT OF PATIENTS WHO HAVE HAD NEW CORONAVIRUS INFECTION WITH LUNG DAMAGE IN THE EARLY RECOVERY PERIOD | 2022 |
|
RU2801234C1 |
| METHOD OF BREATHING EXERCISES FOR PATIENTS WITH COVID-ASSOCIATED PNEUMONIA | 2022 |
|
RU2784605C1 |
| METHOD FOR MEDICAL REHABILITATION OF PATIENTS WITH VIRAL PNEUMONIA ASSOCIATED WITH CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2772211C1 |
| METHOD FOR REHABILITATION OF PATIENTS WHO HAVE UNDERGONE A NEW CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2782499C1 |
| METHOD OF REHABILITATION, COMBINING HYPO- AND HYPERBARIC OXYGENATION, FOR PATIENTS SUFFERING NEW CORONAVIRUS INFECTION | 2023 |
|
RU2821549C1 |
| METHOD FOR COMPREHENSIVE REHABILITATION OF PATIENTS AFTER COVID-19 CORONAVIRUS INFECTION | 2021 |
|
RU2778774C1 |
